medigraphic.com

2010, Number 3

<< Back Next >>

Med Sur 2010; 17 (3)

Tumor carcinoide duodenal. Reporte de un caso

Bahena-Aponte JA, Chávez-Tapia N, Pérez GCM, Robles AJA

Language: Spanish
References: 11
Page: 137-140
PDF size: 71.77 Kb.


ABSTRACT

Introduction. Carcinoids tumors of the small bowel represents only 1 to 2% of gastrointestinal neoplasm. Case report. This case is a patient with specific symptoms diagnosed by duodenal biopsy specimens, treated with complete resection. Discussion. Small bowel carcinoid tumors are diagnosed commonly in an advanced stage due the lack of specific symptoms. There is a direct relation between tumor size and risk of developing metastasis. Complete surgical resection is the standard treatment with overall survival rate at 5 years of 70-90%.


REFERENCES

  1. Koornstra JJ, de Vries EG, Porte RJ. Improvements in small bowel carcinoid diagnosis and staging: (18)F-DOPA PET, capsule endoscopy and double balloon enteroscopy. Dig Liver Dis 2008 Jul 5 (Epub ahead of Print).

  2. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics 2010. CA Cancer J Clin 2010; 7: 225-249.

  3. DiSario JA, Buró RW, Vargas H, McWhorther WP. Small bowel cancer: Epidemiological and clinical characteristics from a population- based registry. Am J Gastroenterol 1994; 89: 699-701.

  4. Hatzaras I, Palesty A, Abir F, et al. Small-Bowsel tumors: Epidemiologic and clinical characteristics of 1260 cases from the connesticut tumor registry. Arch Surg 2007; 142: 229-35.

  5. Thompson GB. Carcinoids tumors of the gastrointestinal tract: Presentation, management, and prognosis. Surgery 1990; 98: 1054-63.

  6. Modlin IM, MossSF, Cheng DC, Jensen RT, Snyderwine E. Priorities for Improving the Management of gastroenteropancreatic neuroendocrine tumors. J Natl Cancer Inst 2008; 100: 1282-9.

  7. Ritchie G, Stafford WT. Argentafin tumors of the gastrointestinal tract. Arch Path 1974; 58: 223-9.

  8. Mc Donald RA. On 356 carcinoids of the gastrointestinal tract Am J Med 1990; 41: 1867-71.

  9. Kaklamanos IG, Bathe OF, Franceschi D, Camarda C, Levi J, Livinstone AS. Extent of resection in the management of duodenal adenocarcinoma. Am J Surg 2000; 179: 37-41.

  10. Frank M, Klose KJ, Wied M. Combination therapy with octreotide and alpha-interferon: Effect on tumor growth in metastatic endocrine 82gastroenteropancreatic tumors. Am J Gastroenterol 1999; 95: 1381-7.

  11. Modlin IM, Latich I, Zikusoka M, Kidd M, Pick G, Chan AK. Gastroentestinal carcinoids: The evolution of diagnostic strategies. J Clin Gastroenterol 2006; 40; 572-.




2020     |     www.medigraphic.com